Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cardio Risk of Acute Schizophrenia Olanzapine Duke (CRASOD)

This study has been withdrawn prior to enrollment.
(lack of funding)
Sponsor:
Information provided by (Responsible Party):
Duke University
ClinicalTrials.gov Identifier:
NCT00672464
First received: May 4, 2008
Last updated: July 29, 2014
Last verified: July 2014
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: February 2010
  Estimated Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)